Screener
Rapport Therapeutics, Inc. RAPP Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333862
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For The Six Months Ended June 30, 2026 | For The Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total operating expenses | 60,806 | 29,496 | 105,021 | 56,604 |
| Loss from operations | (60,806) | (29,496) | (85,021) | (56,604) |
| Other income: | ||||
| Interest income | 4,191 | 2,764 | 8,549 | 5,809 |
| Total other income | 4,191 | 2,764 | 8,549 | 5,809 |
| Net loss | $(56,615) | $(26,732) | $(76,472) | $(50,795) |
| Net loss per share attributable to common stockholders, basic and diluted | $(1.19) | $(0.75) | $(1.61) | $(1.44) |
| Weighted-average common shares outstanding, basic and diluted | 47,473,174 | 35,444,635 | 47,355,550 | 35,356,098 |
Item 1. Financial Statements.
FAQ
- What is Rapport Therapeutics, Inc.'s interest income?
- Rapport Therapeutics, Inc. (RAPP) reported interest income of $4.19M in Q2 2026.
- How has Rapport Therapeutics, Inc.'s interest income changed year-over-year?
- Rapport Therapeutics, Inc.'s interest income increased by 51.6% year-over-year, from $2.76M to $4.19M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s interest income?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s interest income has grown at a 132.1% compound annual growth rate (CAGR), from $2.53M to $13.62M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Rapport Therapeutics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude